InfuSystem Holdings (INFU) EPS (Diluted) Growth (1y) (2011 - 2026)
InfuSystem Holdings (INFU) EPS (Diluted) Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.95 Bn | 193.35 Bn | 7.27 Bn | -47.60% |
| 2 | Stryker | 128.10 Bn | 124.63 Bn | 4.50 Bn | 44.49% |
| 3 | Medtronic | 118.91 Bn | 109.69 Bn | 6.41 Bn | 18.72% |
| 4 | Boston Scientific | 73.43 Bn | 72.89 Bn | 3.85 Bn | 15.24% |
| 5 | Edwards Lifesciences | 51.91 Bn | 47.66 Bn | 1.35 Bn | -25.88% |
| 6 | Dexcom | 34.52 Bn | 32.58 Bn | 830.00 Mn | 44.97% |
| 7 | GE HealthCare Technologies | 33.94 Bn | 31.83 Bn | 2.18 Bn | 15.81% |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn | 71.72% |
| 9 | Steris | 23.14 Bn | 22.66 Bn | 684.20 Mn | 13.96% |
| 10 | InfuSystem Holdings | 243.66 Mn | 242.70 Mn | 21.41 Mn | 26.25% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 26.25% |
| Mar 31, 2026 | 567.39% |
| Dec 31, 2025 | 124.51% |
| Sep 30, 2025 | 30.82% |
| Jun 30, 2025 | 282.98% |
| Mar 31, 2025 | 79.87% |
| Dec 31, 2024 | 881.61% |
| Sep 30, 2024 | 148.68% |
| Jun 30, 2024 | 60.10% |
| Mar 31, 2024 | -259.57% |
| Dec 31, 2023 | -30.75% |
| Sep 30, 2023 | 60.53% |
| Jun 30, 2023 | 352.76% |
| Mar 31, 2023 | 10.15% |
| Dec 31, 2022 | -63.51% |
| Sep 30, 2022 | 194.85% |
| Jun 30, 2022 | -120.88% |
| Mar 31, 2022 | -151.51% |
| Dec 31, 2021 | -96.43% |
| Sep 30, 2021 | -116.04% |